Cognitive Consequences of High Aβ Amyloid in Mild Cognitive Impairment and Healthy Older Adults: Implications for Early Detection of Alzheimer's Disease

被引:28
|
作者
Lim, Yen Ying [1 ,2 ]
Ellis, Kathryn A. [1 ,3 ,4 ]
Harrington, Karra [1 ]
Kamer, Adrian [1 ]
Pietrzak, Robert H. [5 ]
Bush, Ashley I. [1 ]
Darby, David [1 ]
Martins, Ralph N. [6 ]
Masters, Colin L. [1 ]
Rowe, Christopher C. [7 ,8 ,9 ]
Savage, Greg [10 ,11 ]
Szoeke, Cassandra [1 ,4 ,12 ]
Villemagne, Victor L. [1 ,7 ,8 ,13 ]
Ames, David [3 ,4 ]
Maruff, Paul [1 ,14 ]
机构
[1] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Acad Unit Psychiat Old Age, Dept Psychiat, St Georges Hosp, Kew, Vic, Australia
[4] Natl Ageing Res Inst, Parkville, Vic, Australia
[5] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA
[6] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Sch Exercise Biomed & Hlth Sci, Perth, WA, Australia
[7] Austin Hlth, Dept Nucl Med, Heidelberg, Vic, Australia
[8] Austin Hlth, Ctr PET, Heidelberg, Vic, Australia
[9] Univ Melbourne, Heidelberg, Vic, Australia
[10] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia
[11] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia
[12] CSIRO Preventat Hlth Flagship, Parkville, Vic, Australia
[13] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia
[14] CogState Ltd, Melbourne, Vic, Australia
关键词
A beta amyloid; mild cognitive impairment; healthy controls; cognition; POSITRON-EMISSION-TOMOGRAPHY; FLORBETAPIR F 18; EPISODIC MEMORY; NONDEMENTED INDIVIDUALS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DECLINE; BIOMARKERS; POPULATION;
D O I
10.1037/a0032321
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
`Background: It has been proposed that only mild cognitive impairment (MCI) with high A beta amyloid is indicative of incipient Alzheimer's disease (AD), yet MCI with low A beta amyloid may reflect other neurode-generative processes. We aimed to determine the extent to which high A beta amyloid influenced cognitive function in healthy older adults and adults with MCI. Method: Healthy controls ( HC; n = 178) and adults with MCI ( n = 56) enrolled in the Australian Imaging, Biomarkers, and Lifestyle study, underwent positron emission tomography neuroimaging for A beta amyloid and completed an extensive neuropsychological battery, assessing the cognitive domains of verbal and visual episodic memory, executive function, visuoconstruction, attention and processing speed, and language at baseline. Results: MCI with low A beta performed worse than MCI with high A beta on measures of executive function, attention, visuoconstruction and language. No differences were observed between HC high and low A beta groups. When compared with HC with low A beta, both MCI high and low A beta groups performed worse on measures of episodic memory. However, only the MCI low A beta group performed worse than HC low A beta on measures of executive function, attention, visuoconstruction, and language. Conclusions: When compared with HC with low A beta amyloid, MCI with high A beta amyloid present with impairments restricted to episodic memory, and the episodic memory impairments in MCI with low A beta amyloid were accompanied by impairments in executive function, attention, visuoconstruction, and language, suggesting that MCI with high A beta amyloid reflects prodromal AD, although further longitudinal data is required to confirm this.
引用
收藏
页码:322 / 332
页数:11
相关论文
共 50 条
  • [31] Molecular imaging of brain amyloid in mild cognitive impairment and Alzheimer's disease
    Matthews, P. M.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (07): : 366 - 367
  • [32] Effect of physical activity on memory function in older adults with mild Alzheimer's disease and mild cognitive impairment
    Tanigawa, Takanori
    Takechi, Hajime
    Arai, Hidenori
    Yamada, Minoru
    Nishiguchi, Shu
    Aoyama, Tomoki
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2014, 14 (04) : 758 - 762
  • [33] Evidence for Different Trajectories of Delay Discounting in Older Adults With Mild Cognitive Impairment and Mild Alzheimer's Disease
    Thoma, Myriam V.
    Maercker, Andreas
    Forstmeier, Simon
    JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2017, 72 (06): : 956 - 965
  • [34] Early detection of cognitive decline in mild cognitive impairment and Alzheimer's disease with a novel eye tracking test
    Tadokoro, Koh
    Yamashita, Toru
    Fukui, Yusuke
    Nomura, Emi
    Ohta, Yasuyuki
    Ueno, Setsuko
    Nishina, Saya
    Tsunoda, Keiichiro
    Wakutani, Yosuke
    Takao, Yoshiki
    Miyoshi, Takahiro
    Higashi, Yasuto
    Osakada, Yosuke
    Sasaki, Ryo
    Matsumoto, Namiko
    Kawahara, Yuko
    Omote, Yoshio
    Takemoto, Mami
    Hishikawa, Nozomi
    Morihara, Ryuta
    Abe, Koji
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 427
  • [35] A significant difference of memory beliefs, cognitive activity, and depression in healthy older adults, patients with amnestic mild cognitive impairment, and patients with Alzheimer's disease
    Song, I. U.
    Lee, K. S.
    Chung, Y. A.
    Chung, S. W.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [36] Odor Identification and Apolipoprotein E Genotype in Frontotemporal Dementia, Alzheimer's Disease, Mild Cognitive Impairment and Healthy Older Adults
    Kamath, V
    Mechanic-Hamilton, D.
    Seligman, S. C.
    Arnold, S. E.
    Moberg, P. J.
    CLINICAL NEUROPSYCHOLOGIST, 2011, 25 (04) : 540 - 541
  • [37] The cognitive and neural expression of semantic memory impairment in mild cognitive impairment and early Alzheimer's disease
    Joubert, Sven
    Brambati, Simona M.
    Ansado, Jennyfer
    Barbeau, Emmanuel J.
    Felician, Olivier
    Didic, Mira
    Lacombe, Jacinthe
    Goldstein, Rachel
    Chayer, Celine
    Kergoat, Marie-Jeanne
    NEUROPSYCHOLOGIA, 2010, 48 (04) : 978 - 988
  • [38] Imaging and Biomarkers in Early Alzheimer's Disease and Mild Cognitive Impairment
    Petersen, R. C.
    Jack, C. R., Jr.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) : 438 - 441
  • [39] Rates of progression in mild cognitive impairment and early Alzheimer's disease
    Storandt, M
    Grant, EA
    Miller, JP
    Morris, JC
    NEUROLOGY, 2002, 59 (07) : 1034 - 1041
  • [40] Normal aging, mild cognitive impairment, and early Alzheimer's disease
    Petersen, RC
    NEUROLOGIST, 1995, 1 (06) : 326 - 344